CervoMed (CRVO) Equity Ratio (2022 - 2025)
CervoMed (CRVO) has disclosed Equity Ratio for 9 consecutive years, with 0.8 as the latest value for Q4 2025.
- Quarterly Equity Ratio fell 12.47% to 0.8 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.8 through Dec 2025, down 12.47% year-over-year, with the annual reading at 0.8 for FY2025, 12.47% down from the prior year.
- Equity Ratio hit 0.8 in Q4 2025 for CervoMed, down from 0.85 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 7.79 in Q1 2024 to a low of 10.44 in Q2 2023.
- Historically, Equity Ratio has averaged 0.73 across 4 years, with a median of 0.82 in 2025.
- Biggest five-year swings in Equity Ratio: crashed 1038.41% in 2023 and later surged 191.01% in 2024.
- Year by year, Equity Ratio stood at 8.01 in 2022, then soared by 109.24% to 0.74 in 2023, then grew by 23.02% to 0.91 in 2024, then dropped by 12.47% to 0.8 in 2025.
- Business Quant data shows Equity Ratio for CRVO at 0.8 in Q4 2025, 0.85 in Q3 2025, and 0.88 in Q2 2025.